Table 1.
Summary of literature data on the frequency of Yersinia enterocolitica (YE) infection in patients with autoimmune thyroid disease, compared with controls
| Frequency of YE infection | ||||||
|---|---|---|---|---|---|---|
| Applied method for | ||||||
| Reference | Country | YE seroreactivity | Graves’ disease | Hashimoto's disease | Controls | |
| [7] | Germany | Western blot | IgG | 60–81%* | 66%* | 35% |
| IgA | 29–39%* | 37%* | 12% | |||
| [8] | Greece | ELISA | IgG | – | 25·4%* | 1·9% |
| IgA | – | 2·8%* | 0% | |||
| [9] | USA | Western blot | IgG | 96% | 55·5% | 70·8% |
| [10] | Canada | Western blot | IgG | >90% | >90% | >90% |
| ELISA | IgG | Not different from controls | ||||
| Agglutination | O3, O9 | All –ve | All –ve | All –ve | ||
| [11] | Japan | Agglutination | O3 | 27·1% | 40·0% | 29·4% |
| O5 | 81·4%* | 91·1%* | 58·9% | |||
| O6 | 28·6% | 40·0%* | 24·7% | |||
| O9 | 37·1% | 51·1%* | 29·9% | |||
| [12] | Turkey | Agglutination | O3 | 53·8%* | 38·1%* | 17·5% |
| O5 | 29·2%* | 15·8%* | 7·5% | |||
| O8 | 44·6%* | 17·5%* | 7·5% | |||
| O9 | 40·0%* | 22·8%* | 10·0% | |||
*
Significantly different from controls.